3 completed, 2 withdrawn, 1 unknown. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Withdrawn 2, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Vaseline: new trials by email Literature Review of Vaseline trials Research Report on Vaseline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Immunotherapy, Cutaneous Squamous Cell Carcinoma | Phase 2 | Withdrawn | Massachusetts General Hospital | 2026-01-01 | 2025-05-07 | |
| Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Cutaneous Squamous Cell Carcinoma, Actinic Keratoses | Phase 2 | Withdrawn | Massachusetts General Hospital | 2026-01-01 | 2025-05-07 | |
| Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients Medicinal Plant, Salicylate, Vaseline - Keratosis Plantaris | Phase 2 | Completed | Universidade do Vale do Sapucai | 90 | 2017-06-01 | 2020-11-05 |
| Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers Diltiazem Gel 2%, Nitroglycerin Ointment 2%, Vaseline - Digital Ulcer of Scleroderma | Phase 2 | Completed | Mohammad Ali Nazarinia | 90 | 2016-06-01 | 2017-03-06 |
| Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids 2% lidocaine, placebo - Hemorrhoids | Phase 2 / Phase 3 | Unknown | University Hospital Dubrava | 138 | 2013-10-01 | 2013-10-14 |
| The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses Oleogel-S10 100 mg/g, Placebo (petroleum jelly) - Actinic Keratoses | Phase 2 | Completed | Birken AG | 165 | 2008-10-01 | 2015-09-14 |
Keratosis, Actinic (3) · Carcinoma, Squamous Cell (2) · Skin Neoplasms (2) · Callosities (1) · Diabetes Mellitus (1) · Hemorrhoids (1) · Keratosis (1) · Scleroderma, Diffuse (1)
Massachusetts General Hospital (2) · Birken AG (1) · Mohammad Ali Nazarinia (1) · Universidade do Vale do Sapucai (1) · University Hospital Dubrava (1)
United States (2) · Brazil (1) · Croatia (1) · Germany (1) · Greece (1) · Iran (1)
Shadmehr Demehri, MD/PHD (2) · Claus Garbe, Prof. Dr. (1) · Mario Kopljar, MD, PhD (1) · Mohammad Ali Nazarinia, M.D. (1) · Tihomir Kekez (1)
PMID 11934971, PMID 22934545, PMID 23402088, PMID 23494072, PMID 23554239, PMID 24054756, PMID 25124939, PMID 26054651